Target intelligence / Profile preview

Long intergenic non-protein coding RNA 475 (LINC00475)

Target
LINC00475
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 475 (LINC00475) is a human long non-coding RNA (lncRNA) located at chromosome 9q22.31 (also referred to as C9orf44). LINC00475 does not encode a protein but regulates gene expression by acting as a competing endogenous RNA (ceRNA), binding and sequestering microRNAs such as miR-141-3p and miR-376c-3p. Overexpression of LINC00475 is observed in several cancers, including glioma and papillary thyroid carcinoma, where it promotes cell proliferation, migration, and invasion, correlating with poorer prognosis and shorter survival. In glioma, LINC00475 modulates the Hippo pathway by regulating YAP1 expression through miR-141-3p interaction. These findings highlight LINC00475 as a promising diagnostic and therapeutic target, particularly in oncology.

Other names
C9orf44
02

Mechanism of action

Acts as a molecular sponge for microRNAs (e.g., miR-141-3p, miR-376c-3p), thereby regulating downstream pathways involved in cell growth and survival. Modulates YAP1 expression (a key regulator in the Hippo pathway) via sequestration of miR-141-3p. Promotes oncogenesis via deregulation of microRNA availability, affecting multiple cancer-related signaling pathways.

03

Biological functions

Regulation of gene expressionCell proliferationCompeting endogenous RNA (ceRNA) activityCell migrationCell invasion
04

Disease associations

CancerGliomaPapillary thyroid carcinoma (PTC)Other malignancies
05

Safety considerations

No specific safety or toxicity concerns reported, but as a putative therapeutic target in oncology, potential off-target effects or interference with normal gene regulation could be a challenge (general to lncRNA targeting)
06

Biomarkers

Expression levels of LINC00475 as a prognostic biomarker in gliomaPotential role in patient stratification for glioma and possibly other cancers

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 475 (LINC00475).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 475 (LINC00475).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call